Who owns IMPACT BIOMEDICAL INC?
- Ticker: IBO
- CUSIP Number: 45259l205
Tip: Access positions for across all investors
Analyze quarterly positions in Impact Biomedical with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Impact Biomedical stock
Who bought or sold IMPACT BIOMEDICAL INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 815k | $412k | 692% | Dec 2025 |
|
| BlackRock | 260k | $130k | 3% | Dec 2025 |
|
| Geode Capital Management | 74k | $38k | 65% | Dec 2025 |
|
| Two Sigma Investments | 32k | $21k | 39% | Sep 2025 |
|
| Two Sigma Securities | 23k | $12k | -20% | Dec 2025 |
|
| Susquehanna International | 17k | $8.3k | -21% | Dec 2025 |
|
| Jane Street | 14k | $7.1k | 100% | Dec 2025 |
|
| Hrt Financial | 14k | $6.0k | 100% | Dec 2025 |
|
| State Street Corporation | 12k | $6.0k | 0% | Dec 2025 |
|
| Northern Trust | 10k | $5.2k | 100% | Dec 2025 |
|
| Mason & Associates | 10k | $5.1k | 0% | Dec 2025 |
|
| UBS Group | 2.2k | $1.1k | -89% | Dec 2025 |
|
| Tower Research Capital | 1.4k | $719.987400 | -1% | Dec 2025 |
|
| Wells Fargo & Company | 224.00 | $113.008000 | -11% | Dec 2025 |
|
| Newbridge Financial Services Group | 86.00 | $43.000000 | 0% | Dec 2025 |
|
| FMR | 36.00 | $24.001200 | 0% | Sep 2025 |
|
| CWM | 28.00 | $0 | 0% | Dec 2025 |
|
| Signature Resources Capital Management | 4.00 | $2.000000 | 0% | Dec 2025 |
|
| Danske Bank A/s | 3.00 | $2.000100 | 0% | Dec 2025 |
|
| Royal Bank of Canada | 1.00 | $0 | 100% | Sep 2025 |
|
| Group One Trading | 1.00 | $1.000000 | 0% | Dec 2025 |
|